Purification and certain properties of a bacteriocin from Streptococcus mutans

Area of Science:

• Microbiology
• Biochemistry
• Oral Health

Background:

• Streptococcus mutans is a primary causative agent of dental caries.
• Bacteriocins are ribosomally synthesized antimicrobial peptides with potential therapeutic applications.

Purpose of the Study:

• To isolate and characterize an inhibitory substance from Streptococcus mutans strain C3603.
• To evaluate the antimicrobial spectrum and stability of the isolated bacteriocin.
• To assess the efficacy of the bacteriocin in reducing dental caries in vivo.

Main Methods:

• Purification and isolation of the inhibitory factor from Streptococcus mutans C3603.
• Characterization of the bacteriocin's properties including pI, molecular weight, pH stability, and thermal stability.
• Enzyme susceptibility assays to determine proteinaceous nature.
• In vitro susceptibility testing against various bacterial strains.
• In vivo caries reduction study in gnotobiotic and specific pathogen-free rats.

Main Results:

• A bacteriocin, designated Bacteriocin C3603, was purified. It is a basic protein (pI 10, MW 4,800).
• Bacteriocin C3603 exhibited remarkable stability across a wide pH range (1.0-12.0) and high temperatures (100°C for 10 min, 121°C for 15 min).
• The bacteriocin displayed broad-spectrum activity against various Streptococcus and Lactobacillus species, with notable efficacy against specific S. mutans serotypes, and significantly reduced caries scores in rats.

Conclusions:

• Bacteriocin C3603 is a stable, potent antimicrobial agent with bacteriocidal activity against Streptococcus mutans.
• Its effectiveness in reducing dental caries in a rat model suggests its potential as a novel therapeutic agent for caries prevention.